Clinical trial · Observational
Stress, Diurnal Cortisol, and Breast Cancer Survival
NCT00226967CI-TRIAL-00042986completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to learn about the effects of stress on hormones, the relationship between these hormones and cancer progression.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Sandostatin | Drug | — | UNRESOLVED |
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 35 Years
Show eligibility criteria text
Inclusion Criteria: 1. Diagnosis of recurrent or metastatic breast cancer. 2. Karnofsky of 70% or greater. 3. Proficient enough in English to be able to take questionnaires and participate in the required tasks. 4. Living within the Greater Bay Area. 5. Age 35 or older . Exclusion Criteria: 1. Positive supraclavicular lymph nodes as the only metastatic lesion at the time of initial diagnosis. 2. Active cancers within the past 10 years other than breast cancer, basal cell or squamous cell carcinomas of the skin, or in situ cancer of the cervix. 3. Any other serious medical condition that will effect short term survival 4. History of major psychiatric illness for which patient was hospitalized or medicated, with the exception of depression or anxiety 5. A diagnosis of diabetes.
References
Publications (0)
Data not yet available
No reference posted for this study.